Relationship between renal resistance index and renal function in liver transplant recipients after cessation of calcineurin inhibitor

Clinical Transplantation

Volumn 23, Issue 4, 2009, Pages 499-504

  Eisenberger, Ute ^a   Sollinger, Daniel ^a   Stickel, Felix ^b   Burckhardt, Beat ^b   Frey, Felix J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Calcineurin inhibitor toxicity; M TOR inhibitor; Renal disease in liver transplantation; Renal hemodynamics; Renal resistance index; Ultrasound

Indexed keywords

CALCINEURIN INHIBITOR; CHOLESTEROL; CREATININE; RAPAMYCIN; UREA;

ADULT; ARTERIAL STIFFNESS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER TRANSPLANTATION; LOADING DRUG DOSE; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RENAL RESISTANCE INDEX; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL;

AGED; CALCINEURIN; CREATININE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RENAL CIRCULATION; RENAL INSUFFICIENCY; SIROLIMUS;

EID: 68349128453     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.00986.x     Document Type: Article

References (25)

1. Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003: 349: 931.
2. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994: 331: 1110.
3. Nankivell BJ, Borrows RJ, Fung CL et al. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 2004: 78: 557.
4. Schlitt HJ, Barkmann A, Boker KH et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: A randomised controlled study. Lancet 2001: 357: 587.
5. Raimondo ML, Dagher L, Papatheodoridis GV et al. Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Transplantation 2003: 75: 186.
6. Reich DJ, Clavien PA, Hodge EE. Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: Randomized, prospective, multicenter pilot study results. Transplantation 2005: 80: 18.
7. Shenoy S, Hardinger KL, Crippin J et al. Sirolimus conversion in liver transplant recipients with renal dysfunction: A prospective, randomized, single-center trial. Transplantation 2007: 83: 1389.
8. Watson CJ, Gimson AE, Alexander GJ et al. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl 2007: 13: 1694.
9. Neff GW, Montalbano M, Slapak-Green G et al. Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency. Transplant Proc 2003: 35: 3029.
10. Lam P, Yoshida A, Brown K et al. The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors. Dig Dis Sci 2004: 49: 1029.
11. Fairbanks KD, Eustace JA, Fine D et al. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus. Liver Transpl 2003: 9: 1079.
12. Daniel C, Ziswiler R, Frey B et al. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative. Exp Nephrol 2000: 8: 52.
13. van den Akker JM, Wetzels JF, Hoitsma AJ. Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients. Kidney Int 2006: 70: 1355.
14. Marti HP, Frey FJ. Nephrotoxicity of rapamycin: An emerging problem in clinical medicine. Nephrol Dial Transplant 2005: 20: 13.
15. Koda M, Murawaki Y, Kawasaki H. Renovascular resistance assessed by color Doppler ultrasonography in patients with chronic liver diseases. J Gastroenterol Hepatol 2000: 15: 1424.
16. Radermacher J, Mengel M, Ellis S et al. The renal arterial resistance index and renal allograft survival. N Engl J Med 2003: 349: 115.
17. Sollinger D, Mohaupt MG, Wilhelm A et al. Arterial stiffness assessed by digital volume pulse correlates with comorbidity in patients with ESRD. Am J Kidney Dis 2006: 48: 456.
18. Wissmann C, Frey FJ, Ferrari P et al. Acute cyclosporine-induced nephrotoxicity in renal transplant recipients: The role of the transplanted kidney. J Am Soc Nephrol 1996: 7: 2677.
19. Weingart C, Leingartner T, Bergler T et al. Increase in renal vascular resistance after intake of cyclosporin A and tacrolimus and reversal by nitroglycerin spray: A study in patients with stable renal allograft function. Int J Clin Pharmacol Ther 2006: 44: 422.
20. Heine GH, Girndt M, Sester U et al. No rise in renal Doppler resistance indices at peak serum levels of cyclosporin A in stable kidney transplant patients. Nephrol Dial Transplant 2003: 18: 1639.
21. Radermacher J, Ellis S, Haller H. Renal resistance index and progression of renal disease. Hypertension 2002: 39: 699.
22. Heine GH, Reichart B, Ulrich C et al. Do ultrasound renal resistance indices reflect systemic rather than renal vascular damage in chronic kidney disease? Nephrol Dial Transplant 2007: 22: 163.
23. Bumbea V, Kamar N, Ribes D et al. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant 2005: 20: 2517.
24. Saurina A, Campistol JM, Piera C et al. Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: Changes in glomerular haemodynamics and proteinuria. Nephrol Dial Transplant 2006: 21: 488.
25. Straathof-Galema L, Wetzels JF, Dijkman HB et al. Sirolimus-associated heavy proteinuria in a renal transplant recipient: Evidence for a tubular mechanism. Am J Transplant 2006: 6: 429.